ACTIVE

NDC PHARMA

Export PDF
Financial year 2025 · closed on 30/06/2025
Net result
188,4 k €
+85.6% YoY
Gross margin
440,8 k €
+16.2% YoY
Equity
234,1 k €
+0.3% YoY
Workforce
3,2 ETP
0.0% YoY

What does NDC PHARMA do?

NDC PHARMA is a Public limited company incorporated in 1986. Its registered office is in Hooglede. It employs on average 3,2 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0429.465.124
Incorporation
26/09/1986
Legal form
Public limited company
Registered office
Bruggestraat 2
8830 Hooglede · FlandreSee on map
Contributed capital
70 000,00 €
Latest accounts
30/06/2025
Average workforce
3,2 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 16 financial years

2025202420232022201820162015201420132012201120102009200820072006
Income statement
Gross margin440,8 k €379,5 k €340,3 k €326,7 k €402,7 k €254,9 k €215,7 k €219,9 k €233,2 k €194,3 k €199,5 k €201,7 k €240,3 k €219,5 k €231,5 k €213,2 k €
EBITDA215,7 k €155,4 k €129,7 k €139,8 k €126,5 k €82,3 k €54,6 k €72 k €110,6 k €69,1 k €91,1 k €95,6 k €137,5 k €135,6 k €155,6 k €130,1 k €
Operating result200,6 k €114 k €126,1 k €136,2 k €29,1 k €18,3 k €-4,3 k €13,1 k €51,9 k €11 k €37,2 k €83,2 k €124,8 k €119,2 k €137,3 k €85,3 k €
Net result188,4 k €101,5 k €121,4 k €153,3 k €16,5 k €9,7 k €-14,1 k €1,4 k €41,2 k €-14,5 k €104,3 k €76,7 k €102,8 k €99,1 k €103,5 k €62,8 k €
Balance sheet
Equity234,1 k €233,4 k €232,8 k €232,7 k €287,7 k €290,2 k €292 k €306,1 k €304,7 k €293,5 k €308 k €253,7 k €227 k €174,2 k €171,1 k €167,1 k €
Total assets772,9 k €768,5 k €542,5 k €561,3 k €721,9 k €809,7 k €773,3 k €840,9 k €917,3 k €969 k €1 M €958,9 k €450,6 k €449,7 k €458,8 k €442,5 k €
Cash105,2 k €180,7 k €133 k €66,4 k €76,2 k €59,1 k €23,1 k €19,7 k €69,1 k €40,5 k €107,2 k €213 k €113,9 k €106,7 k €139,9 k €111,2 k €
Debts538,8 k €535,1 k €309,7 k €328,7 k €410 k €493,9 k €452,6 k €507,3 k €584,2 k €646,1 k €681,4 k €705,2 k €223,6 k €275,5 k €287,4 k €259,9 k €
Other
Workforce3,2 ETP3,2 ETP3,2 ETP3,2 ETP3,4 ETP3,5 ETP3,2 ETP3,2 ETP2,7 ETP2,5 ETP2,7 ETP2,4 ETP1,8 ETP1,6 ETP1,8 ETP2,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 7 ended

Active mandates

PHARMA WORLD

Director · since 01 avril 2005 · 0871.420.581

Represented by Decloedt NELE

Active

Ended mandates

Koen Sap

Director · since 30 juin 2016 · until 09 décembre 2022

Ended
PHARMA WORLD

Managing director · since 30 juin 2016 · until 09 décembre 2022 · 0871.420.581

Represented by Nele Decloedt

Ended
PHARMA WORLD

Managing director · since 30 juin 2016 · until 09 décembre 2022 · 0871.420.581

Represented by Nele Decloedt (vaste vertegenwoordiger)

Ended
Koen Sap

Director

Ended
At this address

Other companies at this address

CompanyCBE no.
Vereniging van mede-eigenaars Residentie Gulden Sporen E te Hooglede, Bruggestraat 2● Active
0505.722.069
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/12/202510/01/202519/01/202431/01/202317/01/202215/12/2020
General meeting12/12/202513/12/202422/12/202323/12/202224/12/202111/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

19 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/06/202512/12/202529/12/2025DutchPDF
Abridged model30/06/202413/12/202410/01/2025DutchPDF
Abridged model30/06/202322/12/202319/01/2024DutchPDF
Abridged model30/06/202223/12/202231/01/2023DutchPDF
Abridged model30/06/202124/12/202117/01/2022DutchPDF
Abridged model30/06/202011/12/202015/12/2020DutchPDF
Abridged model30/06/201913/12/201915/01/2020DutchPDF
Abridged model30/06/201814/12/201817/12/2018DutchPDF
Abridged model31/12/201629/06/201725/07/2017DutchPDF
Abridged model31/12/201530/06/201612/07/2016DutchPDF
Abridged model31/12/201425/06/201515/07/2015DutchPDF
Abridged model31/12/201326/06/201425/07/2014DutchPDF
Abridged model31/12/201227/06/201317/07/2013DutchPDF
Abridged model31/12/201130/06/201213/07/2012DutchPDF
Abridged model31/12/201030/06/201115/07/2011DutchPDF
Abridged model31/12/200924/06/201025/06/2010DutchPDF
Abridged model31/12/200825/06/200925/06/2009DutchPDF
Abridged model31/12/200726/06/200809/07/2008DutchPDF
Abridged model31/12/200628/06/200704/07/2007DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 7 ended

Active mandates

PHARMA WORLD

Director · since 01 avril 2005 · 0871.420.581

Represented by Decloedt NELE

Active

Ended mandates

Koen Sap

Director · since 30 juin 2016 · until 09 décembre 2022

Ended
PHARMA WORLD

Managing director · since 30 juin 2016 · until 09 décembre 2022 · 0871.420.581

Represented by Nele Decloedt

Ended
PHARMA WORLD

Managing director · since 30 juin 2016 · until 09 décembre 2022 · 0871.420.581

Represented by Nele Decloedt (vaste vertegenwoordiger)

Ended
Koen Sap

Director

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates03/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other08/06/2017
    BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates17/02/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/07/2010
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/04/2006
    BENAMING - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates09/05/2005
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/07/2004
    ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025188,4 k €↑
  2. 2024
    Annual accounts 2024101,5 k €↓
  3. 2023
    Annual accounts 2023121,4 k €↓
  4. 2023
    Name changeNDC PHARMA
  5. 2022
    Annual accounts 2022153,3 k €↑
  6. 2022
    Name changeSAP - DECLOEDT
  7. 2018
    Annual accounts 201816,5 k €↑
  8. 2016
    Annual accounts 20169,7 k €↑
  9. 2015
    Annual accounts 2015-14,1 k €↓
  10. 2014
    Annual accounts 20141,4 k €↓
  11. 2013
    Annual accounts 201341,2 k €↑
  12. 2012
    Annual accounts 2012-14,5 k €↓
  13. 2011
    Annual accounts 2011104,3 k €↑
  14. 2010
    Annual accounts 201076,7 k €↓
  15. 2009
    Annual accounts 2009102,8 k €↑
  16. 2008
    Annual accounts 200899,1 k €↓
  17. 2007
    Annual accounts 2007103,5 k €↑
  18. 2006
    Annual accounts 200662,8 k €
  19. 26/09/1986
    IncorporationPublic limited company